Quantitative Assessment of Iron Accumulation in the Deep Gray Matter of Multiple Sclerosis by Magnetic Field Correlation Imaging

References

1. ↵
   Minagar A. Gray matter involvement in multiple sclerosis: a new window into pathogenesis. J Neuroimaging 2003;13:291–92

   CrossRefPubMed
2. ↵
   Filippi M. Multiple sclerosis: a white matter disease with associated gray matter damage. J Neurol Sci 2001;185:3–4

   CrossRefPubMedWeb of Science
3. ↵
   Cifelli A, Arridge M, Jezzard P, et al. Thalamic neurodegeneration in multiple sclerosis. Ann Neurol 2002;52:650–53

   CrossRefPubMedWeb of Science
4. ↵
   Wylezinska M, Cifelli A, Jezzard P, et al. Thalamic neurodegeneration in relapsing-remitting multiple sclerosis. Neurology 2003;60:1949–54

   Abstract/FREE Full Text
5. ↵
   Inglese M, Liu S, Babb JS, et al. Three-dimensional proton spectroscopy of deep gray matter nuclei in relapsing-remitting MS. Neurology 2004;631:170–72
6. ↵
   Carone DA, Benedict RH, Dwyer MG, et al. Semi-automatic brain region extraction (SABRE) reveals superior cortical and deep gray matter atrophy in MS. Neuroimage 2006;29:505–14

   CrossRefPubMedWeb of Science
7. ↵
   Bermel RA, Puli SR, Rudick RA, et al. Prediction of longitudinal brain atrophy in multiple sclerosis by gray matter magnetic resonance imaging T2 hypointensity. Arch Neurol 2005;62:1371–76

   CrossRefPubMedWeb of Science
8. ↵
   Bartzokis G, Tishler TA, Shin IS, et al. Brain ferritin iron as a risk factor for age at onset in neurodegenerative diseases. Ann N Y Acad Sci 2004;1012:224–36

   CrossRefPubMedWeb of Science
9. ↵
   Campbell A, Smith MA, Sayre LM, et al. Mechanisms by which metals promote events connected to neurodegenerative diseases. Brain Res Bull 2001;55:125–32

   CrossRefPubMed
10. ↵
    Levine SM, Chakrabarty A. The role of iron in the pathogenesis of experimental allergic encephalomyelitis and multiple sclerosis. Ann N Y Acad Sci 2004;1012:252–66

    CrossRefPubMedWeb of Science
11. ↵
    Xu S, Jordan EK, Brocke S, et al. Study of relapsing remitting experimental allergic encephalomyelitis SJL mouse model using MION-46L enhanced in vivo MRI: early histopathological correlation. J Neurosci Res 1998;52:549–58

    CrossRefPubMedWeb of Science
12. Mehindate K, Sahlas DJ, Frankel D, et al. Proinflammatory cytokines promote glial heme oxygenase-1 expression and mitochondrial iron deposition: implications for multiple sclerosis. J Neurochem 2001;77:1386–95

    CrossRefPubMedWeb of Science
13. Ruuls SR, Bauer J, Sontrop K, et al. Reactive oxygen species are involved in the pathogenesis of experimental allergic encephalomyelitis in Lewis rats. J Neuroimmunol 1995;56:207–17

    CrossRefPubMedWeb of Science
14. ↵
    Forge JK, Pedchenko TV, LeVine SM. Iron deposits in the central nervous system of SJL mice with experimental allergic encephalomyelitis. Life Sci 1998;63:2271–84

    CrossRefPubMedWeb of Science
15. ↵
    Bakshi R, Dmochowski J, Shaikh ZA, et al. Gray matter T2 hypointensity is related to plaques and atrophy in the brains of multiple sclerosis patients. J Neurol Sci 2001;185:19–26

    CrossRefPubMedWeb of Science
16. ↵
    Drayer BP, Burger P, Hurwitz B, et al. Magnetic resonance imaging in multiple sclerosis: decreased signal in thalamus and putamen. Ann Neurol 1987;22:546–50

    CrossRefPubMedWeb of Science
17. ↵
    Amato MP, Ponziani G, Siracusa G, et al. Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years. Arch Neurol 2001;58:1602–06

    CrossRefPubMedWeb of Science
18. ↵
    Ge Y, Udupa JK, Nyul LG, et al. Numerical tissue characterization in MS via standardization of the MR image intensity scale. J Magn Reson Imaging 2000;12:715–21

    CrossRefPubMedWeb of Science
19. ↵
    Bakshi R, Benedict RH, Bermel RA, et al. T2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study. Arch Neurol 2002;59:62–68

    CrossRefPubMedWeb of Science
20. ↵
    Jensen JH, Johnson G, Chandra R, et al. MRI measurement of magnetic field correlation in a cell suspension. Proc Intl Soc Mag Reson Med Berkeley, Calif: International Society for Magnetic Resonance in Medicine. Toronto, Canada;2003;11:1120
21. Helpern JA, Jensen J, Lee SP, et al. Quantitative MRI assessment of Alzheimer's disease. J Mol Neurosci 2004;24:45–48

    CrossRefPubMed
22. ↵
    Jensen JH, Chandra R, Ramani A, et al. Magnetic field correlation imaging. Magn Reson Med 2006;55:1350–61

    CrossRefPubMedWeb of Science
23. ↵
    Jensen JH, Chandra R. Method for measuring the magnetic field correlation function for water protons in biological tissues. Proc Intl Soc Mag Reson Med Berkeley, Calif: International Society for Magnetic Resonance in Medicine. Honolulu, Hawaii;2002;10:2297
24. ↵
    Ramani A, Jensen JH, Krain AL, et al. In vivo detection of age-related brain iron differences with MFC. Proc Intl Soc Mag Reson Med Berkeley, Calif: International Society for Magnetic Resonance in Medicine. Seattle, Wash;2006;14:1559
25. ↵
    Udupa JK, Odhner D, Samarasekera S, et al. 3D VIEWNIX: an open, transportable, multidimensional, multimodality, multiparametric imaging software system. Proc Intl Soc Optical Eng 1994;2164:58–73
26. ↵
    Udupa JK, Wei L, Samarasekera S, et al. Multiple sclerosis lesion quantification using fuzzy-connectedness principles. IEEE Trans Med Imaging 1997;16:598–609

    CrossRefPubMedWeb of Science
27. ↵
    Miszkiel KA, Paley MN, Wilkinson ID, et al. The measurement of R2, R2* and R2′ in HIV-infected patients using the prime sequence as a measure of brain iron deposition. Magn Reson Imaging 1997;15:1113–19

    CrossRefPubMedWeb of Science
28. ↵
    Clark PR, Chua-anusorn W, St Pierre TG. Bi-exponential proton transverse relaxation rate (R2) image analysis using RF field intensity-weighted spin density projection: potential for R2 measurement of iron-loaded liver. Magn Reson Imaging 2003;21:519–30

    CrossRefPubMed
29. ↵
    Grimaud J, Millar J, Thorpe JW, et al. Signal intensity on MRI of basal ganglia in multiple sclerosis. J Neurol Neurosurg Psychiatry 1995;59:306–08

    Abstract/FREE Full Text
30. ↵
    Tjoa CW, Benedict RH, Weinstock-Guttman B, et al. MRI T2 hypointensity of the dentate nucleus is related to ambulatory impairment in multiple sclerosis. J Neurol Sci 2005;234:17–24

    CrossRefPubMedWeb of Science
31. ↵
    LeVine SM, Macklin WB. Iron-enriched oligodendrocytes: a reexamination of their spatial distribution. J Neurosci Res 1990;26:508–12

    CrossRefPubMedWeb of Science
32. ↵
    Moos T, Morgan EH. The metabolism of neuronal iron and its pathogenic role in neurological disease: review. Ann N Y Acad Sci 2004;1012:14–26

    CrossRefPubMedWeb of Science
33. ↵
    Dietrich RB, Bradley WG Jr. Iron accumulation in the basal ganglia following severe ischemic-anoxic insults in children. Radiology 1988;168:203–06

    PubMedWeb of Science
34. ↵
    Craelius W, Migdal MW, Luessenhop CP, et al. Iron deposits surrounding multiple sclerosis plaques. Arch Pathol Lab Med 1982;106:397–99

    PubMedWeb of Science
35. ↵
    Drayer B, Burger P, Hurwitz B, et al. Reduced signal intensity on MR images of thalamus and putamen in multiple sclerosis: increased iron content? AJR Am J Roentgenol 1987;149:357–63

    PubMedWeb of Science
36. ↵
    Grant SM, Wiesinger JA, Beard JL, et al. Iron-deficient mice fail to develop autoimmune encephalomyelitis. J Nutr 2003;133:2635–38

    Abstract/FREE Full Text
37. ↵
    Thompson KJ, Shoham S, Connor JR. Iron and neurodegenerative disorders. Brain Res Bull 2001;55:155–64

    CrossRefPubMedWeb of Science
38. ↵
    Bowern N, Ramshaw IA, Clark IA, et al. Inhibition of autoimmune neuropathological process by treatment with an iron-chelating agent. J Exp Med 1984;160:1532–43

    Abstract/FREE Full Text
39. ↵
    Pedchenko TV, LeVine SM. Desferrioxamine suppresses experimental allergic encephalomyelitis induced by MBP in SJL mice. J Neuroimmunol 1998;84:188–97

    CrossRefPubMedWeb of Science